Ruiying He

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Prevalence of Hepatitis D and Its Impact on the Clinical Efficacy of Antiretroviral Therapy in People With HBV/HIV-1 in Guangdong Province, China.

Prevalence of Hepatitis D and Its Impact on the Clinical Efficacy of Antiretroviral Therapy in People With HBV/HIV-1 in Guangdong Province, China.

Journal: Open forum infectious diseases

Published: September 05, 2025

Comparison of classic and novel human astrovirus MLB and VA seroprevalence in HIV and non-HIV cohorts in South China demonstrates high seroreactivity to classic human astrovirus, which is associated with HIV infection.

Comparison of classic and novel human astrovirus MLB and VA seroprevalence in HIV and non-HIV cohorts in South China demonstrates high seroreactivity to classic human astrovirus, which is associated with HIV infection.

Journal: Microbiology spectrum

Published: June 18, 2025

Molecular characterization of HIV-1 near-full-length proviral quasispecies in monocytes from patients across different virological responses.

Molecular characterization of HIV-1 near-full-length proviral quasispecies in monocytes from patients across different virological responses.

Journal: Frontiers in microbiology

Published: June 16, 2025

Genomic surveillance of SARS-CoV-2 variants in Guangzhou, China, from April 2023 to March 2024.

Genomic surveillance of SARS-CoV-2 variants in Guangzhou, China, from April 2023 to March 2024.

Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Published: February 15, 2025

High concordance of human immunodeficiency virus-1 genotypic drug resistance generated from paired cerebrospinal fluid and plasma in antiretroviral therapy -naive or -experienced patients.

High concordance of human immunodeficiency virus-1 genotypic drug resistance generated from paired cerebrospinal fluid and plasma in antiretroviral therapy -naive or -experienced patients.

Journal: Frontiers in microbiology

Published: October 29, 2024

Full genomic sequence characterization of the chikungunya virus from an imported case with serum viral concentration below culturable level.

Full genomic sequence characterization of the chikungunya virus from an imported case with serum viral concentration below culturable level.

Journal: Biosafety and health

Published: June 15, 2024

Performance of a novel viral load assay for plasma HIV-1 RNA quantification compared with Roche real time PCR in China.

Performance of a novel viral load assay for plasma HIV-1 RNA quantification compared with Roche real time PCR in China.

Journal: Journal of virological methods

Published: June 01, 2024

Prevalence of bacteria, fungi, and virus coinfections with SARS-CoV-2 Omicron variant among patients with severe COVID-19 in Guangzhou, China, winter 2022.

Prevalence of bacteria, fungi, and virus coinfections with SARS-CoV-2 Omicron variant among patients with severe COVID-19 in Guangzhou, China, winter 2022.

Journal: Biosafety and health

Published: December 02, 2023

Identification of a novel HIV-1 third-generation circulating recombinant form (CRF126_0755) in Guangdong, China.

Identification of a novel HIV-1 third-generation circulating recombinant form (CRF126_0755) in Guangdong, China.

Journal: Archives of virology

Published: November 19, 2023

Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011-2022: A Retrospective Study.

Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011-2022: A Retrospective Study.

Journal: Infection and drug resistance

Published: May 02, 2023

HIV-1 tropism in low-level viral load HIV-1 infections during HAART in Guangdong, China.

HIV-1 tropism in low-level viral load HIV-1 infections during HAART in Guangdong, China.

Journal: Frontiers in microbiology

Published: February 06, 2023

Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients.

Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients.

Journal: Frontiers in immunology

Published: August 15, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026